600201 生物股份
已收盘 05-21 15:00:00
资讯
新帖
简况
股市必读：*ST四环（000518）新发布《中审亚太会计师事务所关于对江苏四环生物股份有限公司2025年年报问询函的回复》
证券之星 · 05-20 04:32
股市必读：*ST四环（000518）新发布《中审亚太会计师事务所关于对江苏四环生物股份有限公司2025年年报问询函的回复》
股市必读：*ST四环（000518）新发布《江苏四环生物股份有限公司关于对深圳证券交易所2025年年报问询函回复的公告》
证券之星 · 05-19 01:34
股市必读：*ST四环（000518）新发布《江苏四环生物股份有限公司关于对深圳证券交易所2025年年报问询函回复的公告》
生物股份（600201）披露2025年年度股东会决议公告，5月18日股价下跌5.0%
证券之星 · 05-18
生物股份（600201）披露2025年年度股东会决议公告，5月18日股价下跌5.0%
每周股票复盘：生物股份（600201）拟回购注销796.79万股
证券之星 · 05-17
每周股票复盘：生物股份（600201）拟回购注销796.79万股
5月15日生物股份涨7.14%，养殖ETF国泰基金重仓该股
证券之星 · 05-15
5月15日生物股份涨7.14%，养殖ETF国泰基金重仓该股
生物股份涨7.14%，中航证券二周前给出“买入”评级
证券之星 · 05-15
生物股份涨7.14%，中航证券二周前给出“买入”评级
上汽集团、康龙化成目标价涨幅超50%；生物股份评级被调低｜券商评级观察
南方财经网 · 05-15
上汽集团、康龙化成目标价涨幅超50%；生物股份评级被调低｜券商评级观察
生物股份跌7% 华创证券昨日维持推荐评级
中金财经 · 05-13
生物股份跌7% 华创证券昨日维持推荐评级
5月13日生物股份跌7.00%，养殖ETF国泰基金重仓该股
证券之星 · 05-13
5月13日生物股份跌7.00%，养殖ETF国泰基金重仓该股
生物股份（600201）股东内蒙古金宇生物控股有限公司质押245万股，占总股本0.22%
证券之星 · 05-12
生物股份（600201）股东内蒙古金宇生物控股有限公司质押245万股，占总股本0.22%
中航证券：给予生物股份买入评级
证券之星 · 04-29
中航证券：给予生物股份买入评级
每周股票复盘：生物股份（600201）一季度净利增5.44%
证券之星 · 04-26
每周股票复盘：生物股份（600201）一季度净利增5.44%
生物股份（600201）2026年一季报简析：净利润同比增长5.44%，公司应收账款体量较大
证券之星 · 04-24
生物股份（600201）2026年一季报简析：净利润同比增长5.44%，公司应收账款体量较大
生物股份（600201）披露2026年第一季度报告，4月23日股价下跌1.54%
证券之星 · 04-23
生物股份（600201）披露2026年第一季度报告，4月23日股价下跌1.54%
图解生物股份年报：第四季度单季净利润同比下降1.07%
证券之星 · 04-23
图解生物股份年报：第四季度单季净利润同比下降1.07%
每周股票复盘：生物股份（600201）子公司获准生产口蹄疫应急疫苗
证券之星 · 04-12
每周股票复盘：生物股份（600201）子公司获准生产口蹄疫应急疫苗
生物股份(600201.SH)子公司获准生产紧急免疫用口蹄疫疫苗
智通财经 · 04-07
生物股份(600201.SH)子公司获准生产紧急免疫用口蹄疫疫苗
每周股票复盘：生物股份（600201）子公司获新兽药注册证
证券之星 · 03-29
每周股票复盘：生物股份（600201）子公司获新兽药注册证
生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%
证券之星 · 03-26
生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%
生物股份(600201.SH)子公司取得新兽药注册证书
智通财经 · 03-26
生物股份(600201.SH)子公司取得新兽药注册证书
加载更多
公司概况
公司名称：
金宇生物技术股份有限公司
所属行业：
医药制造业
上市日期：
1999-01-15
主营业务：
金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。
发行价格：
6.83
{"stockData":{"symbol":"600201","market":"SH","secType":"STK","nameCN":"生物股份","latestPrice":13.32,"timestamp":1779346800000,"preClose":13.86,"halted":0,"volume":27000729,"delay":0,"changeRate":-0.039,"floatShares":1112000000,"shares":1112000000,"eps":0.0938,"marketStatus":"已收盘","change":-0.54,"latestTime":"05-21 15:00:00","open":13.9,"high":14,"low":13.27,"amount":367000000,"amplitude":0.0527,"askPrice":13.33,"askSize":305,"bidPrice":13.32,"bidSize":591,"shortable":0,"etf":0,"ttmEps":0.0938,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779413400000},"marketStatusCode":5,"adr":0,"adjPreClose":13.86,"symbolType":"stock","openAndCloseTimeList":[[1779327000000,1779334200000],[1779339600000,1779346800000]],"highLimit":15.25,"lowLimit":12.47,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1111747826,"isCdr":false,"pbRate":2.71,"roa":"--","peRate":142.004264,"roe":"1.49%","epsLYR":0.09,"committee":0.420641,"marketValue":14808000000,"turnoverRate":0.0243,"status":1,"floatMarketCap":14808000000},"requestUrl":"/m/hq/s/600201","defaultTab":"news","newsList":[{"id":"2636864709","title":"股市必读：*ST四环（000518）新发布《中审亚太会计师事务所关于对江苏四环生物股份有限公司2025年年报问询函的回复》","url":"https://stock-news.laohu8.com/highlight/detail?id=2636864709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636864709?lang=zh_cn&edition=full","pubTime":"2026-05-20 04:32","pubTimestamp":1779222732,"startTime":"0","endTime":"0","summary":"江苏四环生物股份有限公司关于公司股票交易撤销退市风险警示暨停复牌的公告江苏四环生物股份有限公司股票交易自2026年5月19日开市起停牌1天，于2026年5月20日开市起复牌并撤销退市风险警示。关于江苏四环生物股份有限公司2025年年报问询函相关事项的法律意见书江苏四环生物股份有限公司收到深圳证券交易所关于2025年年报的问询函，针对公司申请撤销股票交易退市风险警示事项，律师结合年审会计师意见进行核查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000005497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","600201","BK0028","BK0196","BK0012","BK0086","BK0145","000518","BK0168","BK0077","BK0239","BK0046","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636082550","title":"股市必读：*ST四环（000518）新发布《江苏四环生物股份有限公司关于对深圳证券交易所2025年年报问询函回复的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2636082550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636082550?lang=zh_cn&edition=full","pubTime":"2026-05-19 01:34","pubTimestamp":1779125650,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，*ST四环报收于3.1元，下跌4.02%，换手率2.62%，成交量26.96万手，成交额8490.19万元。江苏四环生物股份有限公司关于公司股票交易撤销退市风险警示暨停复牌的公告江苏四环生物股份有限公司股票交易自2026年5月19日开市起停牌1天，于2026年5月20日开市起复牌并撤销退市风险警示。证券简称由“*ST四环”变更为“四环生物”，证券代码保持000518不变，股票交易日涨跌幅限制由5%调整为10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900002013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0012","000518","BK0168","BK0086","BK0145","BK0196","BK0188","BK0239","BK0077","399001","BK0028","BK0046","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636712840","title":"生物股份（600201）披露2025年年度股东会决议公告，5月18日股价下跌5.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636712840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636712840?lang=zh_cn&edition=full","pubTime":"2026-05-18 22:13","pubTimestamp":1779113623,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，生物股份报收于14.25元，较前一交易日下跌5.0%，最新总市值为158.42亿元。该股当日开盘15.3元，最高15.35元，最低14.1元，成交额达9.93亿元，换手率为6.19%。近日，生物股份发布《2025年年度股东会决议公告》。公告显示，金宇生物技术股份有限公司于2026年5月18日召开2025年年度股东会，会议由董事会召集，董事长张翀宇主持，采用现场与网络投票相结合方式召开。出席会议的股东及代理人共415人，代表有表决权股份总数的15.642%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800037290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","600201","BK0028","BK0185","BK0188","BK0012","BK0239","BK0196","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636069226","title":"每周股票复盘：生物股份（600201）拟回购注销796.79万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636069226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636069226?lang=zh_cn&edition=full","pubTime":"2026-05-17 01:18","pubTimestamp":1778951891,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：生物股份拟回购注销2023年员工持股计划未解锁股票796.79万股。股本股东变化：股东金宇生物控股累计质押公司股份18,270,000股，占总股本1.64%。因2023年员工持股计划首次授予部分第三个解锁期公司层面业绩考核未达成，且11名持有人离职，公司拟回购注销未解锁股票796.79万股，回购价格为6.23元/股；同时注销回购专用证券账户中使用期限满三年的股份330.16万股。股东内蒙古金宇生物控股有限公司持有公司股份125,510,800股，占总股本的11.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","BK0012","BK0196","BK0239","BK0188","BK0077","BK0028","BK0046","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635822704","title":"5月15日生物股份涨7.14%，养殖ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635822704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635822704?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:20","pubTimestamp":1778833202,"startTime":"0","endTime":"0","summary":"证券之星消息，5月15日生物股份涨7.14%，收盘报15.0元，换手率7.28%，成交量80.98万手，成交额12.23亿元。重仓生物股份的前十大公募基金请见下表：该股最近90天内共有5家机构给出评级，买入评级2家，增持评级3家；过去90天内机构目标均价为15.6。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共17家，其中持有数量最多的公募基金为国泰基金的养殖ETF国泰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500028715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0185","BK0046","BK0077","159865","BK0196","600201","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635048067","title":"生物股份涨7.14%，中航证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2635048067","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635048067?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:19","pubTimestamp":1778833185,"startTime":"0","endTime":"0","summary":"今日生物股份涨7.14%，收盘报15.0元。2026年4月29日，中航证券研究员陈翼,彭海兰发布了对生物股份的研报《主业经营具备韧性，非瘟疫苗望添增量》，该研报对生物股份给出“买入”评级。研报中预计公司2026-2028年归母净利润分别为1.3亿元、2.1亿元、2.9亿元，EPS分别为0.12元、0.18元、0.26元，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为39.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500028708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635778885","title":"上汽集团、康龙化成目标价涨幅超50%；生物股份评级被调低｜券商评级观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2635778885","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635778885?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:49","pubTimestamp":1778806140,"startTime":"0","endTime":"0","summary":"南方财经5月15日电，南财投研数据显示，5月14日，券商给予上市公司目标价共37次，按最新收盘价计算，目标价涨幅排名居前的公司有上汽集团、康龙化成、立昂微，目标价涨幅分别为61.67%、51.58%、49.37%，分别属于乘用车、医疗服务、半导体行业。评级调低方面，5月14日，券商调低上市公司评级达到1家次，国投证券对生物股份的评级从“买入”调低至“增持”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605153738144473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["600104","600201","03759","300759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635207042","title":"生物股份跌7% 华创证券昨日维持推荐评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2635207042","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635207042?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:36","pubTimestamp":1778664983,"startTime":"0","endTime":"0","summary":"中国经济网北京5月13日讯 生物股份(600201.SH)今日收报14.21元，跌幅7.00%。\r\n\r\n \r\n\r\n 华创证券有限责任公司研究员陈鹏昨日发布研报《生物股份(600201)2025年报及2026年一季报点评：传统主业优势延续》称，维持“推荐”评级。\r\n\r\n \r\n\r\n \r\n\r\n (责任编辑：马欣)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260513/32221032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161027","600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635014872","title":"5月13日生物股份跌7.00%，养殖ETF国泰基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635014872","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635014872?lang=zh_cn&edition=full","pubTime":"2026-05-13 16:26","pubTimestamp":1778660817,"startTime":"0","endTime":"0","summary":"证券之星消息，5月13日生物股份跌7.00%，收盘报14.21元，换手率4.99%，成交量55.42万手，成交额7.99亿元。重仓生物股份的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家；过去90天内机构目标均价为14.0。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共17家，其中持有数量最多的公募基金为国泰基金的养殖ETF国泰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300029298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0077","159865","BK0196","600201","BK0028","BK0012","BK0188","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634290501","title":"生物股份（600201）股东内蒙古金宇生物控股有限公司质押245万股，占总股本0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634290501","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634290501?lang=zh_cn&edition=full","pubTime":"2026-05-12 18:29","pubTimestamp":1778581763,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份5月12日公开信息显示，股东内蒙古金宇生物控股有限公司向浙商证券股份有限公司合计质押245.0万股，占总股本0.22%。质押详情见下表：截止本公告日，股东内蒙古金宇生物控股有限公司已累计质押股份1827.0万股，占其持股总数的14.56%。生物股份主营业务：兽用生物制品的研发、生产与销售,产品种类涵盖猪、禽、反刍和宠物类四大系列百余种动物疫苗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200034076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0046","BK0012","600201","BK0188","BK0239","BK0196","BK0028","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631557149","title":"中航证券：给予生物股份买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2631557149","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631557149?lang=zh_cn&edition=full","pubTime":"2026-04-29 12:29","pubTimestamp":1777436982,"startTime":"0","endTime":"0","summary":"中航证券有限公司彭海兰,陈翼近期对生物股份进行研究并发布了研究报告《主业经营具备韧性，非瘟疫苗望添增量》，给予生物股份买入评级。 投资建议 生物股份是国内以研发创新为驱动的头部动保企业。我们预计公司2026-2028年归母净利润分别为1.3亿元、2.1亿元、2.9亿元，EPS分别为0.12元、0.18元、0.26元，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家；过去90天内机构目标均价为14.0。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900040949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630801382","title":"每周股票复盘：生物股份（600201）一季度净利增5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630801382","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630801382?lang=zh_cn&edition=full","pubTime":"2026-04-26 02:00","pubTimestamp":1777140043,"startTime":"0","endTime":"0","summary":"本周关注点来自业绩披露要点：生物股份2026年一季度归母净利润8064.3万元，同比上升5.44%。股本股东变化股东户数变动截至2026年3月31日，生物股份股东户数为4.48万户，较2025年12月31日增加1477.0户，增幅3.41%。公司公告汇总金宇生物技术股份有限公司2026年第一季度报告显示，报告期内营业收入为346,463,052.95元，同比下降1.45%；归属于上市公司股东的净利润为80,643,017.03元，同比增长5.44%；扣除非经常性损益的净利润为64,486,287.26元，同比增长9.27%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600000609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0077","BK0196","600201","BK0028","BK0012","BK0188","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629384260","title":"生物股份（600201）2026年一季报简析：净利润同比增长5.44%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2629384260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629384260?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:30","pubTimestamp":1777037414,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期生物股份发布2026年一季报。截至本报告期末，公司营业总收入3.46亿元，同比下降1.45%，归母净利润8064.3万元，同比上升5.44%。本报告期生物股份公司应收账款体量较大，当期应收账款占最新年报归母净利润比达694.94%。去年的净利率为6.84%，算上全部成本后，公司产品或服务的附加值一般。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400063475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629884710","title":"生物股份（600201）披露2026年第一季度报告，4月23日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629884710","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629884710?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:41","pubTimestamp":1776937300,"startTime":"0","endTime":"0","summary":"截至2026年4月23日收盘，生物股份报收于14.08元，较前一交易日下跌1.54%，最新总市值为156.53亿元。该股当日开盘14.16元，最高14.29元，最低13.93元，成交额达2.99亿元，换手率为1.91%。公司于当日披露《金宇生物技术股份有限公司2026年第一季度报告》。利润总额为96,686,207.01元，同比增长0.75%。经营活动产生的现金流量净额为11,407,954.85元，同比减少56.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300048962.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0196","BK0185","BK0028","600201","BK0188","BK0012","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629029199","title":"图解生物股份年报：第四季度单季净利润同比下降1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629029199","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629029199?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:16","pubTimestamp":1776878166,"startTime":"0","endTime":"0","summary":"证券之星消息，生物股份2025年年报显示，当年度公司主营收入13.96亿元，同比上升11.23%；归母净利润1.0亿元，同比下降8.14%；扣非净利润4974.43万元，同比上升0.52%；其中2025年第四季度，公司单季度主营收入3.54亿元，同比上升24.37%；单季度归母净利润-6120.12万元，同比下降1.07%；单季度扣非净利润-6509.31万元，同比上升32.95%；负债率16.04%，投资收益-202.89万元，财务费用-5006.99万元，毛利率53.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300002482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626223911","title":"每周股票复盘：生物股份（600201）子公司获准生产口蹄疫应急疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2626223911","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626223911?lang=zh_cn&edition=full","pubTime":"2026-04-12 01:41","pubTimestamp":1775929270,"startTime":"0","endTime":"0","summary":"截至2026年4月10日收盘，生物股份报收于14.96元，较上周的14.46元上涨3.46%。本周，生物股份4月8日盘中最高价报15.54元。4月7日盘中最低价报14.48元。生物股份当前最新总市值166.32亿元，在动物保健板块市值排名1/10，在两市A股市值排名1232/5196。本周关注点公司公告汇总：子公司获准生产紧急免疫用口蹄疫南非1型疫苗。公司将配合国家防疫政策推进紧急免疫工作，确保疫苗质量。本次疫苗为应急批准，后续取得正式生产批文存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200000366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0046","BK0028","BK0012","600201","BK0196","BK0188","BK0239","159646","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625935601","title":"生物股份(600201.SH)子公司获准生产紧急免疫用口蹄疫疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2625935601","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625935601?lang=zh_cn&edition=full","pubTime":"2026-04-07 16:38","pubTimestamp":1775551128,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)发布公告，公司全资子公司金宇保灵生物药品有限公司(简称“保灵公司”)获准生产紧急免疫用口蹄疫南非1型亚单位疫苗和口蹄疫南非1型灭活疫苗(Re-SAT1/2026株)。南非1型口蹄疫是由南非1型口蹄疫病毒引起的发病急、传播快、危害大的一类急性高度传染性疾病。主要感染牛、羊、猪等动物，南非1型口蹄疫疫苗获批临时生产后，公司将积极配合国家防疫政策，加快推进紧急免疫工作，严格按照相关要求组织生产，确保疫苗质量，保障畜牧业健康稳定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物股份(600201.SH)子公司获准生产紧急免疫用口蹄疫疫苗","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","600201","BK0012","BK0196","BK0239","BK0188","BK0077","BK0028","BK0046","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623580338","title":"每周股票复盘：生物股份（600201）子公司获新兽药注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2623580338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623580338?lang=zh_cn&edition=full","pubTime":"2026-03-29 03:09","pubTimestamp":1774724950,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，生物股份报收于13.96元，较上周的14.6元下跌4.38%。本周，生物股份3月23日盘中最高价报14.37元。本周关注点公司公告汇总：子公司金宇优邦取得鹅新城疫、小鹅瘟二联灭活疫苗新兽药注册证书公司公告汇总生物股份全资子公司金宇优邦生物科技（江苏）有限公司联合研制的鹅新城疫、小鹅瘟二联灭活疫苗获农业农村部批准为新兽药。上市前需申请兽药产品批准文号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0239","BK0185","BK0188","BK0196","600201","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622866378","title":"生物股份（600201）披露子公司取得新兽药注册证书公告，3月26日股价下跌1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622866378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622866378?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:08","pubTimestamp":1774534101,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，生物股份报收于13.66元，较前一交易日下跌1.44%，最新总市值为151.86亿元。该股当日开盘13.77元，最高13.92元，最低13.55元，成交额达2.15亿元，换手率为1.41%。近日，生物股份发布关于子公司取得新兽药注册证书的公告。该疫苗用于预防鹅新城疫和小鹅瘟，种鹅免疫产生期为二免后21日，免疫期5个月，雏鹅被动免疫期20日。产品需在2～8℃保存，有效期12个月。上市前需申请兽药产品批准文号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600043903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0185","BK0046","BK0077","BK0196","600201","BK0239","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622121832","title":"生物股份(600201.SH)子公司取得新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2622121832","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622121832?lang=zh_cn&edition=full","pubTime":"2026-03-26 16:04","pubTimestamp":1774512272,"startTime":"0","endTime":"0","summary":"智通财经APP讯，生物股份(600201.SH)公告，公司全资子公司金宇优邦生物科技(江苏)有限公司(简称“金宇优邦”)与其他单位联合研制的鹅新城疫、小鹅瘟二联灭活疫苗(A-VII株+GPVP3/Bac株)获批准为新兽药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物股份(600201.SH)子公司取得新兽药注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0046","BK0077","BK0196","600201","BK0028","BK0012","BK0188","BK0185"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779379960901,"stockEarnings":[{"period":"1week","weight":-0.0246},{"period":"1month","weight":-0.0441},{"period":"3month","weight":-0.1064},{"period":"6month","weight":0.1786},{"period":"1year","weight":0.9031},{"period":"ytd","weight":-0.0803}],"compareEarnings":[{"period":"1week","weight":-0.0189},{"period":"1month","weight":0.0196},{"period":"3month","weight":0.0196},{"period":"6month","weight":0.0853},{"period":"1year","weight":0.2312},{"period":"ytd","weight":0.0487}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"金宇生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44780人(较上一季度增加3.41%)","perCapita":"24826股","listingDate":"1999-01-15","address":"内蒙古自治区呼和浩特市土默特左旗经济技术开发区沙尔沁工业园区金宇大街1号","registeredCapital":"111174万元","survey":" 金宇生物技术股份有限公司的主营业务是兽用生物制品的研发、生产与销售。公司的主要产品是猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。","listedPrice":6.83},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物股份,600201,生物股份股票,生物股份股票老虎,生物股份股票老虎国际,生物股份行情,生物股份股票行情,生物股份股价,生物股份股市,生物股份股票价格,生物股份股票交易,生物股份股票购买,生物股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物股份(600201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物股份(600201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}